The Latest Breaking News from Novavax

Leading biotech company Novavax (NVAX) has received temporary approvals for the use of its COVID-19 vaccine from several countries and has filed for emergency use authorization from the U.S. FDA. However, with several high-efficacy vaccines already available in the market, will NVAX be able to successfully commercialize its COVID-19 vaccine…

South Australia's public health chief says dancing in public settings will stay all but banned for the start of the Fringe and the festival season, despite other states relaxing similar restrictions in recent days.

Australians aged 18 and over can now get Novavax as their first and second vaccine for COVID-19. Officials are hoping that the protein-based formula will provide the "extra push" some may need to get the jab.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Novavax Inc (NASDAQ: NVAX) said that its two-dose COVID-19 vaccine was 

This blog is now closed

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12

South Korea will begin offering Novavax Inc.’s COVID-19 vaccine at hospitals, nursing homes and public health centers next week, adding another tool to fight a fast-developing omicron surge

Face coverings still required in indoor public spaces in Spain; UK records 66,638 daily infections and 206 Covid-linked deaths